Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Medical College of Wisconsin
Sponsor:
Collaborator:
West Virginia University
Information provided by (Responsible Party):
Mehdi Hamadani, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT01665677
First received: August 13, 2012
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)